Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Gross Profit Growth (1y) (2010 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn 9.56%
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn 2.50%
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn 17.34%
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn 10.79%
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn 6.19%
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 6.33%
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn 0.14%
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn 18.33%
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn -10.06%
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn 16.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.14%
Mar 31, 2026 1.11%
Dec 31, 2025 0.94%
Sep 30, 2025 -3.51%
Jun 30, 2025 -2.76%
Mar 31, 2025 -6.11%
Dec 31, 2024 -6.63%
Sep 30, 2024 6.02%
Jun 30, 2024 -2.04%
Mar 31, 2024 -10.07%
Dec 31, 2023 -7.76%
Sep 30, 2023 -9.90%
Jun 30, 2023 -8.23%
Mar 31, 2023 -9.99%
Dec 31, 2022 -0.70%
Sep 30, 2022 -14.64%
Jun 30, 2022 -1.52%
Mar 31, 2022 0.52%
Dec 31, 2021 -13.08%
Sep 30, 2021 18.84%